Impax Laboratories Inc. Feb. 18 announced that Food and Drug Administration has granted final approval of its generic version of Nycomed’s Adoxa (doxycyline monohydrate) 150 milligram capsules.
Adoxa is a tetracycline antibiotic used to treat bacterial infections, the company said.
Impax, based in Hayward, Calif., said it is preparing to launch the product through Global Pharmaceuticals, its generic division.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.